Use of Sildenafil for Treatment of Urinary Incontinence
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Urinary Incontinence
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 50 years and 80 years
- Gender
- Only males
Description
Aim: To determine the effect of sildenafil on urinary incontinence. Episodes of urinary incontinence will be recorded using a 3 day bladder diary. Quantitative assessment of urinary incontinence will be performed at baseline and after treatment using a Pad Test. Muscle strength will be assessed thro...
Aim: To determine the effect of sildenafil on urinary incontinence. Episodes of urinary incontinence will be recorded using a 3 day bladder diary. Quantitative assessment of urinary incontinence will be performed at baseline and after treatment using a Pad Test. Muscle strength will be assessed through use of a perineometer. To evaluate macrocirculatory blood flow in pelvic organs, women will be assessed with noninvasive imaging before and after randomization to sildenafil. Secondary outcomes will include evaluation of muscle and vaginal mucosal thickness.
Tracking Information
- NCT #
- NCT02983461
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Kathleen L Vincent, MD University of Texas
Get Well Soon